Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol-induced myocardial infarction

Aronow, 2006, Epidemiology, pathophysiology, prognosis and treatment of systolic and diastolic heart failure, Cardiol. Rev., 14, 108, 10.1097/01.crd.0000175289.87583.e5

De Biase, 2003, Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2− production, Thromb. Haemost., 90, 317, 10.1160/TH03-02-0105

Nakamura, 2000, Mechanism of antioxidative activity of fluvastatin determination of the active position, Chem. Pharm. Bull., 48, 235, 10.1248/cpb.48.235

Dikshit, 1992, Free radical scavenger mechanisms in experimentally induced ischemia in the rabbit heart and protective effect of verapamil, Arch. Int. Pharmacodyn. Ther., 318, 55

Hanada, 1995, Structure–function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax, J. Biol. Chem., 270, 11962, 10.1074/jbc.270.20.11962

Oltvai, 1993, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell, 74, 609, 10.1016/0092-8674(93)90509-O

Miyashita, 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, 9, 1799

Yang, 1995, Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death, Cell, 80, 285, 10.1016/0092-8674(95)90411-5

Hockenbery, 1991, Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death, Proc. Natl. Acad. Sci., 88, 6961, 10.1073/pnas.88.16.6961

Korsmeyer, 1992, Bcl-2 initiates a new category of oncogenes: regulators of cell death, Blood, 80, 879, 10.1182/blood.V80.4.879.879

Hockenbery, 1993, Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell, 75, 241, 10.1016/0092-8674(93)80066-N

Allsopp, 1993, The proto-oncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis, Cell, 73, 295, 10.1016/0092-8674(93)90230-N

Higuchi, 1998, Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase-3 like proteases, Oncogene, 17, 2753, 10.1038/sj.onc.1202211

Tsuruta, 2008, Degradation of caspase-activated DNase by the ubiquitin–proteasome system, Biochim. Biophys. Acta, 1780, 793, 10.1016/j.bbagen.2007.12.003

Mahato, 1988, Triterpenoidsaponins, Phytochemistry, 27, 3037, 10.1016/0031-9422(88)80001-3

Chen, 2003, High performance liquid chromatographic analysis of bioactive triterpenes in Perilla frutescens, J. Pharm. Biomed. Anal., 32, 1175, 10.1016/S0731-7085(03)00160-2

Liu, 1995, Pharmacology of oleanolic acid and ursolic acid, J. Ethanopharmacol., 49, 57, 10.1016/0378-8741(95)90032-2

Harmand, 2005, Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells, Int. J. Cancer, 114, 1, 10.1002/ijc.20588

Liu, 2005, Oleanolic acid and ursolic acid: research perspectives, J. Ethnopharmacol., 100, 92, 10.1016/j.jep.2005.05.024

Shih, 2004, Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats, Neurosci. Lett., 362, 136, 10.1016/j.neulet.2004.03.011

Somova, 2003, Cardiovascular, antihyperlipidemic and antioxidant effect of oleanolic acid and ursolic acid in experimental hypertension, Phytomedicine, 10, 115, 10.1078/094471103321659807

Somova, 2004, Cardiotonic and antidysrhythmic effects of oleanolic acid and ursolic acids, methyl maslinate and uvaol, Phytomedicine, 11, 121, 10.1078/0944-7113-00329

Saravanan, 2006, Protective effect of ursolic acid on ethanol mediated experimental liver damages in rats, Life Sci., 78, 713, 10.1016/j.lfs.2005.05.060

Lu, 2007, Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose, Biochem. Pharmacol., 74, 1078, 10.1016/j.bcp.2007.07.007

Seth, 1998, Role of Lipistat in protection against isoproterenol-induced myocardial necrosis in rats: a biochemical and histopathological study, Ind. J. Physiol. Pharmacol., 42, 101

Katus, 1991, Diagnostic efficacy of troponin T measurements in acute myocardial infarction, Circulation, 83, 902, 10.1161/01.CIR.83.3.902

Larue, 1993, Cardiac-specific immunoenzymomimetic assay of troponin I in the early phase of acute myocardial infarction, Clin. Chem., 39, 972, 10.1093/clinchem/39.6.972

Niehaus, 1968, Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation, Eur. J. Biochem., 6, 126, 10.1111/j.1432-1033.1968.tb00428.x

Jiang, 1992, Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein, Anal. Biochem., 202, 384, 10.1016/0003-2697(92)90122-N

Rao, 1968, Early onset of lipid peroxidation in rat liver after carbon tetrachloride administration, Exp. Mol. Pathol., 9, 271, 10.1016/0014-4800(68)90041-5

Roe, 1943, The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid, J. Biol. Chem., 11, 145

Baker, 1980, Plasma α-tocopherol in man at various times after ingesting free or acetylated tocopherol, Nutr. Res., 21, 531

Ellman, 1959, Tissue sulfhydryl groups, Arch. Biochem. Biophys., 82, 70, 10.1016/0003-9861(59)90090-6

Lowry, 1951, Protein measurement with Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

Kakkar, 1984, A modified spectrophotometric assay of superoxide dismutase, Ind. J. Biochem. Biophys., 21, 130

Sinha, 1972, Colorimetric assay of catalase, Anal. Biochem., 47, 389, 10.1016/0003-2697(72)90132-7

Rotruck, 1973, Selenium: biochemical role as a component of glutathione peroxidise, Science, 179, 588, 10.1126/science.179.4073.588

Habig, 1974, Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation, J. Biol. Chem., 249, 7130, 10.1016/S0021-9258(19)42083-8

Pinto, 1969, The effect of age and sex on glutathione reductase and glutathione peroxidase activities on aerobic glutathione oxidation in rat liver homogenate, Biochem. J., 112, 109, 10.1042/bj1120109

Hebert, 1996, Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids, J. Immunol., 157, 3105, 10.4049/jimmunol.157.7.3105

Laemmli, 1970, Cleavge of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0

Mair, 1997, Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers?, Clin. Chim. Acta, 257, 99, 10.1016/S0009-8981(96)06436-4

Kurian, 2005, Effect of aqueous extract of the Desmodium gangeticum DC root in the severity of myocardial infarction, J. Ethanopharmacol, 97, 457, 10.1016/j.jep.2004.11.028

Hamm, 2000, A classification of unstable angina revisited, Circulation, 102, 118, 10.1161/01.CIR.102.1.118

Kasap, 2007, Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide, J. Clin. Biochem. Nutr., 41, 50, 10.3164/jcbn.2007007

Gupta, 2008, Diagnosis of acute myocardial infarction: CK-MB versus cTn-T in Indian patients, Ind. J. Clin. Biochem., 23, 89, 10.1007/s12291-008-0021-7

Hamberg, 1974, Isolation and structure of two prostaglandins endoperoxides that cause platelet aggregation, Proc. Natl. Acad. Sci., 71, 345, 10.1073/pnas.71.2.345

Resende, 2006, Antimutagenicity of ursolic and oleanoic acid against doxorubicin-induced clastogenesis in Balb/c mice, Life Sci., 79, 1268, 10.1016/j.lfs.2006.03.038

Sharma, 2001, Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats, Mol. Cell Biochem., 225, 75, 10.1023/A:1012220908636

Balanehru, 1991, Protective effect of oleanolic acid and ursolic acid against lipid peroxidation, Biochem. Int., 24, 981

Benohr, 1974, 184

Ommen, 1991, Irreversible inhibition of rat glutathione S-transferase 1-1 by quinones and their glutathione conjugates, structure–activity relationship and mechanism, Biochem. J., 276, 661, 10.1042/bj2760661

Janero, 1991, Therapeutic potential of vitamin E against myocardial ischemic-reperfusion injury, Free Radic. Biol. Med., 10, 315, 10.1016/0891-5849(91)90038-5

Wefers, 1988, The protection by ascrobate and glutathione against microsomal lipid peroxidation is dependent on vitamin E, Eur. J. Biochem., 174, 353, 10.1111/j.1432-1033.1988.tb14105.x

Meister, 1984, New aspects of glutathione biochemistry and transport selective alterations of glutathione metabolism, Nutr. Rev., 42, 397, 10.1111/j.1753-4887.1984.tb02277.x

Lil, 1988, Antioxidant enzyme systems in rat liver and skeletal muscle, Arch. Biochem. Biophys., 263, 150, 10.1016/0003-9861(88)90623-6

Mangan, 1993, Apoptosis in human monocytes: possible role in chronic inflammatory diseases, J. Periodontol., 64, 461

Tang, 1987, Catecholamine induced cardiac hypertrophy, Can. J. Cardiol., 3, 311

Galvez, 2005, Perindopril regulates beta-agonist-induced cardiac apoptosis, J. Cardiovasc. Pharmacol., 46, 255, 10.1097/01.fjc.0000175234.95831.3e

Gabbianelli, 2004, Lymphocyte DNA damage in rats exposed to pyrethroids: effect of supplementation with vitamins E and C, Toxicol, 203, 17, 10.1016/j.tox.2004.05.012

Jeon, 2002, Phosphoinositide 3-OH kinase/protein kinase B inhibits apoptotic cell death induced by reactive oxygen species in Saccharomyces cerevisiae, J. Biochem., 131, 693, 10.1093/oxfordjournals.jbchem.a003153

Kang, 2010, Myocardium and microvessel endothelium apoptosis at day 7 following reperfused acute myocardial infarction, Microvasc. Res., 79, 70, 10.1016/j.mvr.2009.11.003

Takemura, 2004, Role of apoptosis in remodeling after myocardial infarction, Pharmacol. Ther., 104, 1, 10.1016/j.pharmthera.2004.07.005

Murtuza, 2004, Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium, Proc. Natl. Acad. Sci., 101, 4216, 10.1073/pnas.0306205101

Adams, 1998, The Bcl-2 protein family: arbiters of cell survival, Science, 281, 1322, 10.1126/science.281.5381.1322

Kirshenbaum, 1997, The bcl-2 gene product prevents programmed cell death of ventricular myocytes, Circulation, 96, 1580, 10.1161/01.CIR.96.5.1580

Cohen, 1997, Caspases: the executioners of apoptosis, Biochem. J., 326, 1, 10.1042/bj3260001

Bratton, 2001, Apoptotic death sensor: an organelle’s alter ego?, Trends Pharmacol. Sci., 22, 306, 10.1016/S0165-6147(00)01718-1

Burniston, 2005, β-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle, J. Appl. Physiol., 98, 1379, 10.1152/japplphysiol.00642.2004

Saeed, 2003, Ascorbic acid blocks the growth inhibitory effect of TNF-α on endothelial cell, Exp. Biol. Med., 228, 855, 10.1177/15353702-0322807-12

Simeonova, 1995, Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages, Am. J. Respir. Cell Mol. Biol., 12, 676, 10.1165/ajrcmb.12.6.7539275

Agarwal, 1994, Poly ADP-ribosylation of a 90 kDa protein is involved in TNF-α mediated cytotoxicity, J. Immunol., 153, 473, 10.4049/jimmunol.153.2.473

Lee, 2003, Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo, Am. J. Physiol. Heart Circ. Physiol., 284, 456, 10.1152/ajpheart.00777.2002

Gomez, 2005, Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion, Am. J. Physiol. Heart Circ. Physiol., 289, 2153, 10.1152/ajpheart.00165.2005

Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5

Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169, 10.1016/0092-8674(93)90326-L

Salvesen, 2009, Structure of the Fas/FADD complex: a conditional death domain complex mediating signaling by receptor clustering, Cell Cycle, 8, 2723, 10.4161/cc.8.17.9399

Strasser, 2009, The many roles of FAS receptor signalling in the immune system, Immunity, 30, 180, 10.1016/j.immuni.2009.01.001

Zhu, 2001, Time-dependent apoptotic development and pro-apoptotic genes expression in rat heart after myocardial infarction, Jpn. J. Pharmacol., 86, 355, 10.1254/jjp.86.355